<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	 xmlns:media="http://search.yahoo.com/mrss/" >

<channel>
	<title>Unnatural Amino Acids &#8211; CRI Report</title>
	<atom:link href="https://www.cri-report.com/product-tag/unnatural-amino-acids/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.cri-report.com</link>
	<description>market research vender!</description>
	<lastBuildDate>Tue, 21 Aug 2018 05:22:25 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://www.cri-report.com/wp-content/uploads/2021/01/cropped-shcrilogo-c.jpg</url>
	<title>Unnatural Amino Acids &#8211; CRI Report</title>
	<link>https://www.cri-report.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Global Unnatural Amino Acids Market Research Report &#8211; Forecast to 2023</title>
		<link>https://www.cri-report.com/global-unnatural-amino-acids-market-research-report-forecast-to-2023/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Fri, 17 Aug 2018 09:04:21 +0000</pubDate>
				<guid isPermaLink="false">https://www.cri-report.com/product/import-placeholder-for-180173/</guid>

					<description><![CDATA[<p>Unnatural amino acids are increasingly growing in research stature for pharmaceuticals, food and feed additives, agrochemicals, and other industrial applications.</p>
<p>The post <a rel="nofollow" href="https://www.cri-report.com/global-unnatural-amino-acids-market-research-report-forecast-to-2023/">Global Unnatural Amino Acids Market Research Report &#8211; Forecast to 2023</a> first appeared on <a rel="nofollow" href="https://www.cri-report.com">CRI Report</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>Unnatural amino acids are increasingly growing in research stature for pharmaceuticals, food and <a href="https://www.cri-report.com/southeast-asia-feed-industry/" data-internallinksmanager029f6b8e52c="2359" title="Research Report on Southeast Asia Feed Industry 2023-2032" target="_blank" rel="noopener">feed</a> additives, agrochemicals, and other industrial applications. Some amino acids such as isoleucine, threonine, and hydroxyproline, exhibit second centre of asymmetry and hence can exist in four sterioisomeric forms. The global Unnatural Amino Acids market is segmented on the basis of type, product, application, and end user.<br />
The global unnatural amino acids market is segmented on the basis of types, application, and end user.<br />
On the basis the types, it is segmented into D-phenylalanine, D-histidine, D-tyrosine, D-serine, D-alanine, D-tryptophan, D-cysteine, D-phenylglycine, D-p-hydroxy phenylglycine, D-2-chlorophenylglycine, D-penicillamine, D- proline, D-valine, D-citrulline /D-citrulene, D-lysine, D-leucine, D-glutamic acid, D-methionine, D-aspartic acid, D-arginine, D-cycloserine, and others. D-amino acids &amp; derivatives accounted for the largest market share in 2016.<br />
On the basis of the application, it is segmented into liver diseases, cancer, inflammatory disease, genetic diseases, and others. Liver diseases accounts for the largest market share of 32.6% in 2016.<br />
On the basis of end user it is segmented into <a href="https://www.cri-report.com/southeast-asia-pharmaceutical-industry/" data-internallinksmanager029f6b8e52c="2405" title="Research Report on Southeast Asia Pharmaceutical Industry 2023-2032" target="_blank" rel="noopener">pharmaceutical</a> &amp; biotechnological companies, research laboratories, academic institutes, and others. <a href="https://www.cri-report.com/southeast-asia-pharmaceutical-industry/" data-internallinksmanager029f6b8e52c="2405" title="Research Report on Southeast Asia Pharmaceutical Industry 2023-2032" target="_blank" rel="noopener">Pharmaceutical</a> &amp; biotechnological companies accounts for the largest market share of 37.4% in 2016.<br />
Key Players<br />
The leading market players in the global unnatural amino acids market include BASF SE, Sigma-Aldrich Corporation, Novartis AG, Bayer AG, GlaxoSmithKline plc, AstraZeneca plc, Abbott Laboratories and others.<br />
Study objectives of Unnatural Amino Acids market<br />
• To provide insights about factors influencing and affecting the market growth<br />
• To provide historical and forecast revenues of the market segments and sub-segments with respect to regional and country-level markets<br />
• To provide historical and forecast revenue of the market segments based on types, products, applications, end users, and its sub-segments.<br />
• To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market.<br />
Target Audience<br />
• <a href="https://www.cri-report.com/southeast-asia-pharmaceutical-industry/" data-internallinksmanager029f6b8e52c="2405" title="Research Report on Southeast Asia Pharmaceutical Industry 2023-2032" target="_blank" rel="noopener">Pharmaceutical</a> Companies<br />
• Research and Development (R&amp;D) Companies<br />
• Government Research Institute<br />
• Academic Institutes and Universities<br />
• Medical Research Laboratories<br />
• Market Research and Consulting Service Providers<br />
• Potential Investors<br />
Key Finding<br />
• The global unnatural amino acids market is expected to reach USD 3,290.4 million by 2023 at a CAGR of 12.01%<br />
• DL-amino acids &amp; derivatives is the second largest segment, which is projected grow at a CAGR of 12.44% during the forecast period from 2017-2023<br />
• The Americas captured the largest share of the global market and is expected to reach USD 3,290.4 million by 2023.<br />
• Asia Pacific is the fastest growing region across the globe and is expected to grow at a CAGR of 12.16 % during the forecast period.<br />
The reports also cover country level analysis:<br />
• Americas<br />
• North America<br />
o U.S.<br />
o Canada<br />
• Latin America<br />
• Europe<br />
• Western Europe<br />
o Germany<br />
o France<br />
o U.K<br />
o Italy<br />
o Spain<br />
o Rest Of Western Europe<br />
• Eastern Europe<br />
• Asia Pacific<br />
• Japan<br />
• China<br />
• India<br />
• Republic of Korea<br />
• Rest of Asia-Pacific<br />
• Middle East &amp; Africa<br />
• Middle East<br />
• Africa</p>
<p>Table of Contents:<br />
1 Report Prologue<br />
2 Market Introduction<br />
2.1 Definition<br />
2.2 Scope of Study<br />
2.3 Research Objective<br />
2.4 Assumptions &amp; Limitations<br />
2.4.1 Assumptions<br />
2.4.2 Limitations<br />
2.5 Market Structure<br />
3 Research Methodology<br />
3.1.1 Primary Research Methodology<br />
3.1.2 Secondary Research Methodology<br />
3.1.3 Market Share Analysis<br />
3.1.4 Market Pricing Approach<br />
4 Market Dynamics<br />
4.1 Introduction<br />
4.2 Drivers<br />
4.2.1 Increasing application of unnatural amino acids in Pharmaceuticals (Impact Weightage 40%)<br />
4.2.2 Increasing prevalence of chronic diseases (Impact Weightage 35%)<br />
4.2.3 Increasing demands for new and advanced d<a href="https://www.cri-report.com/carpets-and-rugs-market-global-analysis/" data-internallinksmanager029f6b8e52c="1753" title="Global Carpets and Rugs Market Outlook 2030: Industry Insights &amp; Opportunity Evaluation, 2019-2030" target="_blank" rel="noopener">rugs</a> (Impact Weightage 25%)<br />
4.3 Restraints<br />
4.3.1 Stringent Government Regulation (Impact Weightage 60%)<br />
4.3.2 Lack of research and development sector in underdeveloped region (Impact Weightage 40%)<br />
4.4 Opportunity<br />
4.5 Mega Trends<br />
4.6 Macroeconomic indicators<br />
5 Market Factor Analysis<br />
5.1 Value Chain Analysis<br />
5.1.1 R&amp;D<br />
5.1.2 Manufacturing<br />
5.1.3 Distribution &amp; Sales<br />
5.1.4 Post-sales Monitoring</p>
<p>5.2 Porters Five Forces Model<br />
5.2.1 Bargaining power of suppliers (Medium to High)<br />
5.2.2 Bargaining Power of Buyers (Low to Medium)<br />
5.2.3 Threat of New Entrants (Low to Medium)<br />
5.2.4 Threat of Substitutes (Medium)<br />
5.2.5 Intensity of Rivalry (High)<br />
5.3 Demand &amp; Supply: Gap Analysis<br />
5.4 Pricing Analysis<br />
5.5 Investment Opportunity Analysis<br />
6 Global Unnatural Amino Acids Market, by Type<br />
6.1 Introduction<br />
6.2 D-Amino Acids &amp; Derivatives<br />
6.3 DL-Amino Acids &amp; Derivatives<br />
6.4 β-Amino Acids &amp; Derivatives<br />
6.5 Cyclic Amino Acids &amp; Derivatives<br />
6.6 L-Amino Acid Derivatives<br />
6.7 Gamma-Amino Butyric Acid<br />
6.8 Gamma-Amino-Beta-Hydroxybutyric Acid<br />
6.9 Synthetic -Amino Acids<br />
7 Global Unnatural Amino Acids Market, by Applications<br />
7.1 Introduction<br />
7.2 Liver Diseases<br />
7.3 Cancer<br />
7.4 Inflammatory Disease<br />
7.5 Genetic Diseases<br />
8 Global Unnatural Amino Acids Market, By End User<br />
8.1 Introduction<br />
8.2 <a href="https://www.cri-report.com/southeast-asia-pharmaceutical-industry/" data-internallinksmanager029f6b8e52c="2405" title="Research Report on Southeast Asia Pharmaceutical Industry 2023-2032" target="_blank" rel="noopener">Pharmaceutical</a> &amp; Biotechnological Companies<br />
8.3 Research Laboratories<br />
8.4 Academic Institutes<br />
9 Global Unnatural Amino Acids Market, By Region<br />
9.1 Introduction<br />
9.2 Americas<br />
9.2.1 U.S.<br />
9.2.2 Canada<br />
9.2.3 South America<br />
9.3 Europe<br />
9.3.1 Germany<br />
9.3.2 France<br />
9.3.3 U.K<br />
9.3.4 Italy<br />
9.3.5 Spain<br />
9.3.6 Rest of Western Europe<br />
9.3.7 Eastern Europe<br />
9.4 Asia Pacific<br />
9.4.1 India<br />
9.4.2 China<br />
9.4.3 Jpan<br />
9.4.4 Australia<br />
9.4.5 republic of korea<br />
9.4.6 rest of asia pacific<br />
9.5 The Middle East and Africa<br />
10 Competitive Landscape<br />
10.1 Introduction<br />
10.2 Company Share Analysis<br />
11 Company Profiles<br />
11.1 Aminologics Co<br />
11.1.1 Company Overview<br />
11.1.2 Financials<br />
11.1.3 Products<br />
11.1.4 Stratergy<br />
11.1.5 Key Developments<br />
11.2 BASF SE<br />
11.2.1 Company Overview<br />
11.2.2 Financials<br />
11.2.3 Products<br />
11.2.4 Stratergy<br />
11.2.5 Key Developments<br />
11.3 Sigma-Aldrich Corporation<br />
11.3.1 Company Overview<br />
11.3.2 Financials<br />
11.3.3 Products<br />
11.3.4 Stratergy<br />
11.3.5 Key Developments<br />
11.4 Novartis AG<br />
11.4.1 Company Overview<br />
11.4.2 Financials<br />
11.4.3 Products<br />
11.4.4 Stratergy<br />
11.4.5 Key Developments<br />
11.5 Bayer<br />
11.5.1 Company Overview<br />
11.5.2 Financials<br />
11.5.3 Products<br />
11.5.4 Stratergy<br />
11.5.5 Key Developments<br />
11.6 GlaxoSmithKline plc<br />
11.6.1 Company Overview<br />
11.6.2 Financials<br />
11.6.3 Products<br />
11.6.4 Stratergy<br />
11.6.5 Key Developments<br />
11.7 Abbott<br />
11.7.1 Company Overview<br />
11.7.2 Financials<br />
11.7.3 Products<br />
11.7.4 Stratergy<br />
11.7.5 Key Developments<br />
11.8 AstraZeneca<br />
11.8.1 Company Overview<br />
11.8.2 Financials<br />
11.8.3 Products<br />
11.8.4 Stratergy<br />
11.8.5 Key Developments<br />
11.9 Pfizer<br />
11.9.1 Company Overview<br />
11.9.2 Financials<br />
11.9.3 Products<br />
11.9.4 Stratergy<br />
11.9.5 Key Developments<br />
11.1 AbbVie<br />
11.10.1 Company Overview<br />
11.10.2 Financials<br />
11.10.3 Products<br />
11.10.4 Stratergy<br />
11.10.5 Key Developments<br />
11.11 Enzo-Life-Sciences , Inc<br />
11.11.1 Company Overview<br />
11.11.2 Financials<br />
11.11.3 Products<br />
11.11.4 Stratergy<br />
11.11.5 Key Developments<br />
11.12 CU Chemie Uetikon<br />
11.12.1 Company Overview<br />
11.12.2 Financials<br />
11.12.3 Products<br />
11.12.4 Stratergy<br />
11.12.5 Key Developments<br />
11.13 Yoneyama Yakuhin Kogyo<br />
11.13.1 Company Overview<br />
11.13.2 Financials<br />
11.13.3 Products<br />
11.13.4 Stratergy<br />
11.13.5 Key Developments<br />
11.14 Miat S.p.A.<br />
11.14.1 Company Overview<br />
11.14.2 Financials<br />
11.14.3 Products<br />
11.14.4 Stratergy<br />
11.14.5 Key Developments<br />
11.15 AnaSpec Inc.<br />
11.15.1 Company Overview<br />
11.15.2 Financials<br />
11.15.3 Products<br />
11.15.4 Stratergy<br />
11.15.5 Key Developments<br />
11.16 Ajinomoto Co., Inc.<br />
11.16.1 Company Overview<br />
11.16.2 Financials<br />
11.16.3 Products<br />
11.16.4 Stratergy<br />
11.16.5 Key Developments<br />
12 MRFR Conclusion<br />
12.1 Key Findings<br />
12.1.1 From CEO’s View Point<br />
12.1.2 Unmet Needs<br />
12.2 Key companies to watch<br />
13 Appendix<br />
13.1 Discussion Blue Print</p>
<p>The post <a rel="nofollow" href="https://www.cri-report.com/global-unnatural-amino-acids-market-research-report-forecast-to-2023/">Global Unnatural Amino Acids Market Research Report &#8211; Forecast to 2023</a> first appeared on <a rel="nofollow" href="https://www.cri-report.com">CRI Report</a>.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
